272
Views
4
CrossRef citations to date
0
Altmetric
Review

Synovium and cartilage biomarkers in hemophilic arthropathy

Pages 409-414 | Received 02 Dec 2015, Accepted 11 Jan 2016, Published online: 03 Feb 2016

References

  • Rodriguez-Merchan EC, Jimenez-Yuste V, Aznar JA, et al. Joint protection in haemophilia. Haemophilia. 2011;17(Suppl 2):1–23.
  • Salek SZ, Benson GM, Elezović I, et al. The need for speed in the management of haemophilia patients with inhibitors. Haemophilia. 2011;17:95–102.
  • Krenn V, Morawietz L, Burmester G-R, et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology. 2006;49:358–364.
  • Jansen NW, Roosendaal G, Bijlsma JW, et al. Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: an in vitro study. Arthritis Rheum. 2007;56:199–207.
  • Attur M, Krasnokutsky-Samuels S, Samuels J, et al. Prognostic biomarkers in osteoarthritis. Curr Opin Rheumatol. 2013;25:136–144.
  • Solignac M. Biological markers of osteoarthritis: data from the ECHODIAH cohort (article in French). Presse Med. 2004;33(9 Pt 2):S13–5.
  • Meulenbelt I, Kloppenburg M, Kroon HM, et al. Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study. Ann Rheum Dis. 2006;65:360–365.
  • Mazières B, Garnero P, Guéguen A, et al. Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis. 2006;65:354–359.
  • Scarpellini M, Lurati A, Vignati G, et al. Biomarkers, type II collagen, glucosamine and chondroitin sulfate in osteoarthritis follow-up: the “Magenta osteoarthritis study”. J Orthop Traumatol. 2008;9:81–87.
  • Cibere J, Zhang H, Garnero P, et al. Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthritis Rheum. 2009;60:1372–1380.
  • Hoch JM, Mattacola CG, Medina McKeon JM, et al. Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage. 2011;19:1396–404.
  • Streich NA, Zimmermann D, Schmitt H, et al. Biochemical markers in the diagnosis of chondral defects following anterior cruciate ligament insufficiency. Int Orthop. 2011;35:1633–1637.
  • Ishijima M, Watari T, Naito K, et al. Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis. Arthritis Res Ther. 2011;13:R22.
  • van Spil WE, Jansen NW, Bijlsma JW, et al. Clusters within a wide spectrum of biochemical markers for osteoarthritis: data from CHECK, a large cohort of individuals with very early symptomatic osteoarthritis. Osteoarthritis Cartilage. 2012;20:745–754.
  • van Spil WE, Welsing PM, Kloppenburg M, et al. Cross-sectional and predictive associations between plasma adipokines and radiographic signs of early-stage knee osteoarthritis: data from CHECK. Osteoarthritis Cartilage. 2012;20:1278–1285.
  • Kaneko H, Ishijima M, Doi T, et al. Reference intervals of serum hyaluronic acid corresponding to the radiographic severity of knee osteoarthritis in women. BMC Musculoskelet Disord. 2013 Jan 18;14:34.
  • van Spil WE, Drossaers-Bakker KW, Lafeber FP. Associations of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: data from CHECK, a cohort study of early osteoarthritis. Ann Rheum Dis. 2013;72:29–36.
  • Kumm J, Tamm A, Lintrop M, et al. The value of cartilage biomarkers in progressive knee osteoarthritis: cross-sectional and 6-year follow-up study in middle-aged subjects. Rheumatol Int. 2013;33:903–911.
  • Tanishi N, Yamagiwa H, Hayami T, et al. Usefulness of urinary CTX-II and NTX-I in evaluating radiological knee osteoarthritis: the Matsudai knee osteoarthritis survey. J Orthop Sci. 2014;19:429–436.
  • Valdes AM, Meulenbelt I, Chassaing E, et al. Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type II collagen and their role in prevalence, incidence and progression of osteoarthritis. Osteoarthritis Cartilage. 2014;22:683–689.
  • Wang B, Pramono HK, Cicuttini FM, et al. Association between urinary C-telopeptide fragments of type II collagen and knee structure in middle-aged women without clinical knee disease. Osteoarthritis Cartilage. 2014;22:1136–1141.
  • Ramos YF, Metrustry S, Arden N, et al. Meta-analysis identifies loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide significance. J Med Genet. 2014;51:596–604.
  • Kalaï E, Bahlous A, Bouzid K, et al. The role of type II collagen fragments and X-ray progression of knee osteoarthritis. Ann Biol Clin (Paris). 2014;72:715–721.
  • Park YM, Kim SJ, Lee KJ, et al. Detection of CTX-II in serum and urine to diagnose osteoarthritis by using a fluoro-microbeads guiding chip. Biosens Bioelectron. 2015;67:192–199.
  • van Spil WE, Nair SC, Kinds MB, et al. Systemic biochemical markers of joint metabolism and inflammation in relation to radiographic parameters and pain of the knee: data from CHECK, a cohort of early-osteoarthritis subjects. Osteoarthritis Cartilage. 2015;23:48–56.
  • Dorleijn DM, Luijsterburg PA, Bay-Jensen AC, et al. Association between biochemical cartilage markers and clinical symptoms in patients with hip osteoarthritis: cohort study with 2-year follow-up. Osteoarthritis Cartilage. 2015;23:57–62.
  • van Spil WE, Welsing PM, Bierma-Zeinstra SM, et al. The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK. Osteoarthritis Cartilage. 2015 Mar 26;pii:S1063–4584(15)00865–1. DOI:10.1016/j.joca.2015.03.023. [Epub ahead of print].
  • Lafeber FP, van Spil WE. Osteoarthritis year 2013 in review: biomarkers; reflecting before moving forward, one step at a time. Osteoarthritis Cartilage. 2013;21:1452–1464.
  • Jansen NW, Roosendaal G, Lundin B, et al. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy. Arthritis Rheum. 2009;60:290–8.
  • Karapnar TH, Karadaş N, Özek G, et al. The investigation of relationship between joint findings and serum angiogenic and inflammatory factor levels in severe hemophilia A patients. Blood Coagul Fibrin. 2014;25:703–8.
  • Kidder W, Nguyen S, Larios J, et al. Point-of-care musculoskeletal ultrasound is critical for the diagnosis of hemarthroses, inflammation and soft tissue abnormalities in adult patients with painful haemophilic arthropathy. Haemophilia. 2015;21:530–7.
  • van Vulpen LF, van Meegeren ME, Roosendaal G, et al. Biochemical markers of joint tissue damage increase shortly after a joint bleed; an explorative human and canine in vivo study. Osteoarthritis Cartilage. 2015;23:63–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.